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Edited by Beat ImhofAbstract The incidence of type I allergic disorders has been
increasing worldwide, particularly, the hypersensitivity to food.
We ﬁrst showed that apple condensed tannin (ACT) intake would
inhibit the development of the oral sensitization and that the inhi-
bition could correlate with the rise in the population of TCRcd-T
cells in the intestinal intraepithelial lymphocytes (IEL) using
W/WV mice and B10A mice which were ovalbumin (OVA)-orally
sensitized. Serum OVA-speciﬁc immunoglobulin E and immuno-
globulin G1 titers in the OVA-orally sensitized W/WV and B10A
mice ad libitium fed ACT were extremely inhibited compared to
those of the control. The ACT intakes of OVA-sensitized W/WV
and B10A mice inhibited the immediate reduction of the body
temperature or the rise in serum histamine induced by active sys-
temic anaphylaxis. The proportions of the TCRcd-T cells in the
IEL of the OVA-orally sensitized W/WV and B10A mice ad libi-
tium fed ACT were signiﬁcantly greater than that in the controls.
Furthermore, ACT feeding by itself could induce the rise in the
percentage of the TCRcd-T cells among the IEL of the W/WV
and B10A mice. This suggests that the ACT intake may prevent
the development of food allergies and this eﬀect could be corre-
lated with the rise in the percentage of TCRcd-T cells among
the IEL.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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cell1. Introduction
The apple contains several phenolic substances, i.e., chloro-
genic acid, catechin, epicatechin, phlorizin, rutin, ﬂavonoids,
and condensed tannins [1–7]. Osada et al. demonstrated thatAbbreviations: ACT, apple condensed tannins; IEL, intestinal intraep-
ithelial lymphocytes; OVA, ovalbumin; IgE, immunoglobulin E; IgG1,
immunoglobulin G1; IgG2a, immunoglobulin G2a; FCM, ﬂow cytom-
etry; ASA, active systemic anaphylaxis; MF, Mouse Flat
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doi:10.1016/j.febslet.2005.07.019apple condensed tannins (ACT) are contained in unripe apples
at a ten times higher level than in the ripe ones [8]. ACT is a
mixture of oligomers consisting of chains of ﬂavan-3-ol units
mainly linked through C4–C8 (or C6) bonds [9]. Some of these
substances have physiological and pharmacological activi-
ties. Several authors have reported that oligomeric catechins,
such as ACT, showed antioxidant activities [10,11]. We have
also shown that ACT had an inhibitory eﬀect on histamine
release from both rat basophilic leukemia (RBL-2H3) cells
by antigen stimulation and rat peritoneal mast cells stimu-
lated by compound 48/80 [12,13] and that ACT intake would
improve the symptoms of atopic dermatitis (AD) in patients
with AD [14]. These ﬁndings collectively indicate that ACT
intake may have anti-allergic eﬀects with uniquely active
characteristics.
We have previously shown that mast-cell-deﬁcient
WBB6F1-W/WV mice (W/WVmice) and B10A mice can be
eﬃciently sensitized by the oral administration of an antigen
in the form of gavage [15,16]. These mice should be good
models for studying the eﬀect of food and drug substances
on the development of oral sensitization by food allergens.
In this study, we examined the eﬀects of the ACT feeding
on the oral sensitization by food allergens and on the intesti-
nal intraepithelial lymphocytes (IEL) using ﬂow cytometry
(FCM) analysis.2. Materials and methods
2.1. Mice
Female WBB6F1-W/WV mice (6 weeks, W/WV mice) and female
B10A mice (6 weeks) were purchased from Japan SLC (Hamamatsu,
Shizuoka. Japan) and kept under pathogen-free conditions in our ani-
mal facility for 1 week before use. The mice were maintained in a tem-
perature (23–25 C), humidity (40–60%) and light-controlled
environment with free access to a Mouse Flat (MF) diet (SLC) and
water. The ACT was ad libitium administered to the W/WV mice in
the form of the solution dissolved in distilled water at levels of 0%,
0.1% ACT, 0.5% ACT and 1.0% ACT in terms of the dose-dependent
study. The control group (n = 5, 0%), and three ACT groups (each
n = 5, 0.1%, 0.5% and 1.0%) had free access to water and each ACT
solution with the MF diet. These mice were sensitized by the adminis-
tration of 1.0 mg ovalbumin (OVA; grade V, Sigma Chemical Co, St.
Louis, MO) by daily gavage for 9 weeks. To assess the eﬀect of only the
ACT intake on the population of the lymphocytes in the IEL in W/WV
mice, the 1.0% ACT feeding was investigated without oral sensitization
to OVA for 2 weeks or 9 weeks in W/WV mice.blished by Elsevier B.V. All rights reserved.
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administered to the mice with levels of 1.0% ACT. The control group
(n = 6) and ACT group (n = 6) had free access to water and each ACT
solution with the MF diet. The B10A mice were also sensitized by the
administration of 1.0 mg OVA by daily gavage for 9 weeks. To assess
the eﬀect of only the ACT intake on the population of the lymphocytes
in the IEL of the B10A mice, the 1.0% ACT feeding was investigated
without oral sensitization to OVA for 9 weeks in the B10A mice.
For the examination of the W/WV and the B10A mice, the blank
group (each n = 5–6) normally had free access to water and the MF
diet without the oral sensitization of OVA for 9 weeks. The care and
use of the experimental animals in this study followed ‘‘The Ethical
Guidelines of Animal Care, Handling and Termination’’ prepared by
the National Institute of Health Sciences (NIHS) in Japan.
2.2. Sample preparations
ACT from unripe apples was obtained according to the method re-
ported by Ohnishi-Kameyama et al. [9].
2.3. ELISA for mouse serum anti-OVA IgE, IgG1 and IgG2a titer
The mouse serum titers of anti-OVA immunoglobulin E (IgE),
immunoglobulin G1 (IgG1), and immunoglobulin G2a (IgG2a) were
determined in triplicate in a 96-well microtiter plate by a previously re-
ported method [17,18]. The serum OVA-speciﬁc antibody titers were
calculated by the reciprocal of the serum dilution with the ﬂuorescence
intensity at 50% of the maximum level.
2.4. Induction of active systemic anaphylaxis and measurement of the
body temperature changes and serum histamine level
TheW/WV or B10Amice orally immunized with OVA were intraper-
itoneally challenged with 0.2 ml PBS containing OVA (1 mg/mouse) to
induce active systemic anaphylaxis (ASA) [15]. The body temperature
changes associated with the ASA were monitored with a rectal ther-
mometer for the mice (Shibaura Electronics Co., Ltd., Japan) without
general anesthesia. Ten minutes after OVA challenge, the mice were
killed and their blood was collected to obtain serum for the histamine
determination. The serum histamine concentrations were measured
using the post-columnHPLCmethod described by Kawasaki et al. [19].
2.5. Isolation of mouse IEL
The IEL were isolated as previously described by Nagafuchi et al.
[20].
2.6. FCM analysis
A three-color analysis of the IEL subsets was performed by a previ-
ously reported method [15].Fig. 1. Eﬀects of ACT intake on serum OVA-speciﬁc IgE (A), IgG1 (B) and I
were dissolved in distilled water at levels of 0.1%, 0.5% and 1.0% ACT. Bar
signiﬁcant diﬀerence from the control group value (\P < 0.05).2.7. Statistical analysis
All values are expressed as means ± standard error of the mean. Sta-
tistical comparisons were performed by the Students t test or Scheﬀes
method after an analysis of variances (ANOVA). In all cases, the prob-
ability (P) values below 0.05 were considered signiﬁcant.3. Results
3.1. Body weight and the amount of feed intake
We examined whether ACT intake aﬀects the body weight
and feed intake of the W/WV and B10A mice. There was no
signiﬁcant diﬀerence in the body weight and the amount of
feed intake between the control group and the ACT fed group
during the experimental period. No speciﬁc symptom was ob-
served in the ACT group during the study.3.2. Serum OVA-speciﬁc IgE, IgGl and IgG2a antibody titer
To investigate whether the ACT intake could aﬀect the
development of the OVA-oral sensitization of the W/WV mice,
serum OVA-speciﬁc IgE, IgG1 and IgG2a antibody titers in
the OVA orally-sensitized mice were determined using indirect
ELISA (Fig. 1). In the control group, we conﬁrmed that the
OVA-speciﬁc IgE, IgG1 and IgG2a antibody titers were sub-
stantially detected and the mice were sensitized by the oral
administration of OVA in the form of gavage as previously re-
ported. In contrast, the OVA-speciﬁc IgE and IgG1 titers of
the 1.0% ACT feeding group (1.0% ACT group) were signiﬁ-
cantly lower than those of the control group. In addition,
the OVA-speciﬁc IgE and IgG1 titers of the 0.5% ACT group
was even lower than those of the control group though the
OVA-speciﬁc IgE titers were not signiﬁcantly diﬀerent from
those of the control group. These results suggested that the de-
crease in the OVA-speciﬁc IgE and IgG1 titers by the ACT in-
take appears to be dose-dependent from 0% ACT feeding to
1.0% ACT feeding. Furthermore, during the same examination
of B10A mice, the OVA-speciﬁc IgE titer of 1.0% ACT group
also were signiﬁcantly lower than those of the control group
(Fig. 2).gG2a (C) titers in W/WV mice orally sensitized by OVA. ACT solutions
s represent mean values ± S.E.M. for ﬁve mice. The asterisk indicates
Fig. 2. Eﬀects of ACT intake on serum OVA-speciﬁc IgE (A), IgG1 (B) and IgG2a (C) titers in B10 A mice orally sensitized by OVA. ACT solutions
were dissolved in distilled water at levels of 1.0% ACT. Bars represent mean values ± S.E.M. for six mice. The asterisk indicates signiﬁcant diﬀerence
from the control group value (\\P < 0.01).
Fig. 4. Determination of serum histamine level of B10A mice after
active active systemic anaphylaxis. Asterisk indicates signiﬁcant
diﬀerence from control value (\\P < 0.01). Bars represent mean
values ± S.E.M of four mice.
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stimulation
To investigate the eﬀects of ACT on the OVA-induced
hypersensitivity reaction in this model, the body temperatures
of the sensitized W/WV or B10A mice were measured every
minute for 10 min after intraperitoneal challenge with 1 mg
of OVA. As shown in Fig. 3, intense hypothermia developed
in the control group after challenge for both the W/WV and
B10A mice. However, there was no hyperthermia in the 1.0%
ACT group for both W/WV and B10A mice. Furthermore, a
marked increase in serum histamine occurred in B10A mice
undergoing antigen challenge. The serum histamine level in
the 1.0% ACT group was signiﬁcantly lower than that in the
control group after antigen stimulation of the B10A mice
(Fig. 4).
These results suggest that 1.0% ACT intake could prevent
the development of the food allergies in these models and
could be involved in the inhibition of ACT feeding on the oral
sensitization.
3.4. Flow cytometric analysis of the IEL in W/W and B10A mice
To examine the mechanisms involved in the inhibition of
oral sensitization by the ACT intake, IEL were isolated from
the small intestine of the normal W/WV and B10A mice andFig. 3. Changes in body temperature on the sensitized W/WV mice (A) and B
control at P < 0.05. Each value represents mean values ± S.E.M of ﬁve micetheir lymphocytes were analyzed by FCM. As previously re-
ported [15], the proportion of the TCRcd(TCRabcd+)T cells
in the IEL of the W/WV mice without oral sensitization was
approximately 3.0–5.0% of the blank group at the same exper-
imental point (blank in Table 1). As shown in Table 1, the10A mice (B) after the antigen stimulation. \Signiﬁcantly diﬀerent from
.
Table 1
Flow cytometric analysis of the IEL in W/WV mice
Blank Control 0.1% ACT 0.5% ACT 1.0% ACT 1.0% ACT (non-oral
sens. for 9 weeks)
1% ACT (non-oral
sens. for 2 weeks)
CD3+b7+(T cell) 86.6 ± 6.0 82.6 ± 5.1 84.5 ± 5.5 88.9 ± 3.6 90.1 ± 2.2\ 90.7 ± 2.5\ 89.4 ± 3.8\
CD4+CD8(TCRabCD4) 13.1 ± 2.9 15.8 ± 5.9 12.9 ± 5.9 16.4 ± 4.4 10.7 ± 2.0 7.9 ± 3.0\ 8.0 ± 2.4\
CD4+CD8+(TCRabCD4CD8aa) 24.1 ± 9.2 29.1 ± 5.7 29.0 ± 8.1 33.8 ± 5.1 25.3 ± 7.5 24.7 ± 12.4 10.3 ± 4.2
CD8a+CD8b(CD8aa) 34.9 ± 7.0 37.2 ± 6.1 38.3 ± 4.7 44.6 ± 5.4 49.9 ± 6.1\\ 50.7 ± 6.0\\ 41.7 ± 2.5\\
CD8a+CD8b+(TCRabCD8ab) 39.2 ± 9.8 32.5 ± 8.4 33.9 ± 10.9 30.5 ± 7.1 31.7 ± 8.4 36.5 ± 8.6 43.2 ± 5.1
TCRabcd+(TCRcd) 3.4 ± 1.2 2.0 ± 0.7 2.2 ± 1.2 3.6 ± 1.0\ 10.1 ± 1.7\\ 9.5 ± 3.9\\ 11.5 ± 2.9\\
TCRab+cd(TCRab) 89.4 ± 4.1 90.30 ± 1.45 90.9 ± 1.6 90.7 ± 2.3 84.7 ± 1.9\ 85.0 ± 4.8\ 80.2 ± 4.6\
ACT was ad libitium administered to the W/WV mice in the form of a solution dissolved in distilled water at levels of 0%, 0.1% ACT, 0.5% ACT and
1.0% ACT in terms of the dose-dependent study. The 1.0% ACT with non-oral sens, for 9 weeks (n = 5) and 1.0% ACT with non-oral sens, for 2
weeks (n = 5) were investigated without the oral sensitization of OVA for 9 weeks and 2 weeks, respectively. The values represent mean ± S.E.M. (%
(gated)), \,\\Signiﬁcant diﬀerence from control at P < 0.05 and P < 0.01, respectively.
Table 2
Flow cytometric analysis of IEL in B10A mice
Blank Control 1.0% ACT 1.0% ACT (non-oral sens. for 9 weeks)
CD3+b7+(T cell) 88.9 ± 2.0 84.6 ± 7.6 85.4 ± 3.7 85.7 ± 2.3
CD4+CD8(TCRabCD4) 7.1 ± 2.9 8.5 ± 5.2 6.0 ± 3.1 4.0 ± 1.6
CD4+CD8+(TCRabCD4CD8aa) 15.9 ± 7.4 15.4 ± 7.7 8.5 ± 4.4 9.1 ± 4.1
CD8a+CD8b(CD8aa) 58.0 ± 4.8 54.6 ± 6.0 59.8 ± 6.1 66.7 ± 2.7\\
CD8a+CD8b+(TCRabCD8ab) 23.0 ± 6.3 22.8 ± 2.7 18.0 ± 2.1\\ 17.8 ± 2.8\
TCRabcd+(TCRcd) 27.0 ± 7.1 25.9 ± 5.6 34.6 ± 6.8\\ 34.5 ± 4.9\\
TCRab+cd(TCRab) 61.9 ± 8.1 60.6 ± 5.0 52.0 ± 6.7\\ 53.3 ± 6.1\\
The control group (n = 6) and ACT groups (1.0% ACT, n = 6) had free access to water and 1.0% ACT solution, respectively. The 1.0% ACT with
non-oral sens, for 9 weeks (n = 6) were investigated without the oral sensitization of OVA. The values represent mean ± S.E.M. (% (gated)),
\,\\Signiﬁcantly diﬀerent from control at P < 0.05 and P < 0.01, respectively.
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sensitization shown as the control group (Control in Table 1)
was also conﬁrmed as previously reported [15]. On the other
hand, the proportions of TCRcd-T cells (10.1%) and
CD8aa+T cells (49.9%) of the 1.0% ACT group (1.0% ACT
in Table 1) were signiﬁcantly higher than those of the control
group. The proportion of TCRcd-T cells in the 0.5% ACT
group was slightly increased compared to that of the control
group. These results indicated that the increase in the propor-
tion of the TCRcd-T cells could appear to be ACT dose-depen-
dent up to the 1.0% ACT feeding. Also, in the B10A mice, we
found that the proportions of TCRcd-T cells (34.6%) of the
1.0% ACT group were signiﬁcantly higher than those
(25.9%) of the control group (Table 2, Fig. 5).Fig. 5. Expression of TCRab and TCRcd on IEL from B10A mice. IEL w
sensitized with OVA. The histograms are representatives of six independentFurthermore, to examine the eﬀect of ACT on the popula-
tion of IEL, only 1.0% ACT was ad libitum administered to
the W/WV or B10A mice without the oral sensitization with
OVA. Surprisingly, the proportions of TCRcd-T cells (9.5%)
and CD8aa+T cells (50.7%) of the 1.0% ACT group without
oral sensitization were signiﬁcantly higher than those of the
blank group (3.4% for TCRcd-T cells and 34.9% for CD8aaT
cells) that were not being orally sensitized, as shown in Table 1.
Also, in the B10A mice, the proportions of TCRcd-T cells
(34.5%) and CD8aa+T cells (66.7%) of the 1.0% ACT group
without oral sensitization were signiﬁcantly higher than those
of the blank group (27.0% for TCRcd-T cells and 58.0% for
CD8aa+ T cells). These results suggest that only a 1.0%
ACT intake induced an increase in the percentage ofere isolated from control group (A) and 1.0% ACT group (B) orally
experiments.
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the further examination of feeding only 1.0% ACT in the
W/WV mice for two weeks, the proportions of TCRcd-T cells
(11.5%) and CD8aaT cells (41.7%) of the 1.0% ACT group
with non-oral sensitization were signiﬁcantly higher than those
of the control group for this examination though the propor-
tions of the TCRcd-T cells and CD8aa+T cells in the control
group of this examination was 4.2% and 32.3%, respectively
(approximately 3–5% for TCRcd-T cells and 30–35% for
CD8aa+T cells, respectively, data not shown) and was same
as those of the blank group because of not being orally sensi-
tized (Table 1).
3.5. Association of the proanthocyanidin polymerization of the
ACT structure for the rise of population of the TCRcd-T
cells of IEL in the W/WV mice
In addition, to elucidate the association of the proanthocy-
anidin polymerization of the ACT structure on the increase
in the percentage of the TCRcd-T cells of IEL in the W/WV
mice, only a 1.0% monomer proanthocyanidin solution in
the mixture of (+)-catechin (14.4%) and ()-epicatechin
(83.6%) extracted from apple was ad libitum administered to
the W/WV mice without the oral sensitization with OVA for
two weeks. Interestingly, there was no signiﬁcant diﬀerence be-
tween the proportions of the TCRcd-T cells (4.8%) and
CD8aa+T cells (33.3%) for only the 1.0% mixture of (+)-cate-
chin and ()-epicatechin feeding group and those (5.7% and
32.7%, respectively) of the control group.4. Discussion
In the present study, we ﬁrst showed that ACT intake would
inhibit the development of oral sensitization and that the inhi-
bition could correlate with the rise in the population of
TCRcd-T cells in the IEL of the W/WV mice and B10A mice,
which are highly susceptible to oral sensitization without using
an adjuvant as previously reported [15,16]. In addition, we
showed that the ACT intake of OVA-orally sensitized W/WV
and B10A mice inhibited the immediate reduction of the body
temperature or the rise of serum histamine levels induced by
the antigen stimulation.
Some researchers have developed allergic orally sensitization
mouse models using C3H/HeJ mice [21,22]. However, these
mice have used cholera toxin as an oral adjuvant in order to
be orally-sensitized. Therefore, we considered that the W/WV
and B10A mice should be more appropriate to assess the eﬀect
of food substances on the development of oral sensitization
and the intestinal mucosal immunity system because these mice
can be orally sensitized without using any adjuvants.
Some studies have demonstrated that anaphylactic reactions
can be induced in normal and mast-cell-deﬁcient mice, W/WV
mice, after passive transfer of antigen-speciﬁc IgG1 antibodies
and that these reactions reﬂect the binding of these antibodies
to FccRIII, which can be expressed on the surface of mast cells
as well as other cell types such as macrophages, platelets and
eosinophils in the mouse [23]. Furthermore, it has been shown
that the anaphylactic reactions in mast-cell-deﬁcient mice are
involved in the rise of the plasma platelet-activating factor
(PAF) [15,24]. In the present study, we are considering that
the inhibition of speciﬁc IgG1 antibody production by ACT
feeding could inhibit the immediate reduction of the body tem-perature and anaphylactic reactions induced by the reaction
among antigen, speciﬁc IgG1 antibody and FcyRIII expressed
on some cells, such as macrophages, platelets and eosinophils
in the W/WV mice. While B10A mice normally have mast cells,
the anaphylactic reaction has been thought to be induced by
antigens, antigen-speciﬁc IgE or IgG1 antibody and FceRI ex-
pressed on the mast cells because of the immediate rise in the
serum histamine levels induced by antigens. Therefore, we con-
clude that ACT feeding could inhibit speciﬁc IgG1 and IgE
antibody production induced by oral sensitization and the spe-
ciﬁc IgG1- or IgE-dependent anaphylaxis on the mast cells in
B10A mice.
It has also shown that the percentage of TCRcd-T cells in
the IEL of the W/WV mice should be much lower than those
of the BALB/c mice, and that the W/WV mice are also highly
susceptible to oral sensitization [15]. Furthermore, we have
shown that an additional decrease in the percentage of
TCRcd-T cells in the IEL cells of the W/WV mice was also ob-
served in the orally sensitized W/WV mice [15]. The proportion
of TCRcd-T cells in the IEL of the W/WV mice reconstituted
with bone marrow cells from C57BL/6J increased much more
than that in the untreated W/WV mice and further extremely
inhibited the development of oral sensitization [25]. These ﬁnd-
ings suggested that the lowering of the population of TCRcd-T
cells in the IEL of the W/WV mice could be associated with the
high oral sensitivity of the W/WV mice. In addition, we have
shown that ACT intake can induce the proportion of
TCRcd-T cells and CD8aa+T cells in the IEL of the W/WV
or B10A mice. Most TCRcd-T cells in the IEL are thought
to express CD8aa+ and diﬀerentiate into cryptopatches (CPs)
[26–28]. Therefore, the present study suggests that the ACT in-
take mainly increases the population of the TCRcd-T cells ex-
pressed with CD8aa+ in the IEL.
Although the function of the TCRcd-T cells in the IEL has
not been fully elucidated, several reports have suggested the
involvement of TCRcd-T cells in the IEL in oral tolerance
[29–31] and the allergy crisis [32–34]. McMenamin et al.
showed that systemic tolerance that is induced by exposure
of the respiratory mucosa to OVA activates the TCRcd-T cells
and CD8+ splenic T cells that speciﬁcally suppress IgE re-
sponses to OVA in adoptive recipient rats and mice [35]. These
reports suggest that TCRcd-T cells in the IEL would contrib-
ute to the induction of oral tolerance.
Considering these ﬁndings and our studies, it can be fairly
assumed that ACT intake could prevent the development of
food allergies through the stimulation of the intestinal mucosal
immunity system, and the gut-associated lymphoid tissue cor-
related with oral tolerance, not due to the physical inhibition
of OVA-oral sensitization by ACT.
Condensed tannins are called proanthocyanidins, and have a
wide distribution in plants as secondary metabolites. We con-
sume small amounts of these compounds in daily life from
fresh fruits such as apple and the processed foods made from
these fruits. Rather than nutrients, plant proanthocyanidins
are known as the functional food factors that possess a variety
of physiological activities such as antioxidant [3–6], anti-
allergy, and inhibition against the activities of some physiolog-
ical enzymes and receptors [36,37]. Most of these parts of the
activities of proanthocyanidins appear to depend on their
structures and particularly on their degree of polymerization.
We showed that the mixture of (+)-catechin and ()-epicate-
chin intake in the W/WV mice for two weeks have no eﬀects
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mice. This result suggests that the proanthocyanidin polymer-
ization of the ACT structure would be a critical factor for the
rise in the percentage of TCRcd-T cells of the IEL in the W/
WV mice. The inhibition mechanism of the ACT intake on
the oral sensitization in the W/WV and B10A mice still remains
unclear. However, we presumed that the unique structure of
the catechin polymerization of ACT should contribute to this
activity.
Several clinical medicines prescribed for allergy symptoms,
such as corticosteroids, epinephrine, histamine antagonists,
and leukotriene synthesis inhibitors, interfere with some steps
and lead to the attenuation of the allergic symptoms [6]. How-
ever, the eﬀects of these medicines are often short-lived to re-
duce the allergic responses and induce some side eﬀects.
Therefore, a more fundamental means of preventing the devel-
opment of food allergies should be desirable. Since it has been
thought that IgE-mediated food allergies to egg or cows milk
could be developed in early infancy by failing to induce oral
tolerance [38], we postulate that the ACT intake during early
infancy might prevent the development of food allergies and
may continue to inhibit allergic responses to food proteins
for a lifetime.
Sampson-HA reported that quantiﬁcation of food-speciﬁc
IgE is a useful test for diagnosing symptomatic allergy to
egg, milk, peanut, and ﬁsh in the pediatric population [38].
Therefore, our present mouse models seem to be useful for
examining the eﬀect of bioactive materials to humonal re-
sponses of those food allergens.
In conclusion, we showed that ACT intake could inhibit oral
sensitization with the rise in the population of TCRcd-T cells
in the IEL and may fundamentally be used to prevent food
allergies. In addition, we believe that ACT can be used as a
tool to clarify the role of TCRcd-T cells in the IEL. Further
studies will be necessary to clarify the mechanism of the induc-
tion of oral tolerance by ACT.
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